In the News
![](https://opyl.ai/wp-content/uploads/2022/10/Untitled-design-5-392x286.png)
05/09/23
Opin.AI Breaks Down Barriers in Clinical Trial Participation
![](https://opyl.ai/wp-content/uploads/2023/05/Prepped-and-primed-2023-Opyl-392x286.jpg)
17/01/23
2023 Prepped and Primed: Opyl (ASX:OPL) with CEO, Michelle Gallaher
![](https://opyl.ai/wp-content/uploads/2022/12/2022-in-review-opyl-392x286.jpg)
07/12/22
Year in Review: Opyl (ASX:OPL) with CEO, Michelle Gallaher
![](https://opyl.ai/wp-content/uploads/2022/11/big_data_qantas_november_2022-392x286.jpg)
07/11/22
Big data could cure cancer
![](https://opyl.ai/wp-content/uploads/2023/05/Opyl-640x360-1-392x286.jpg)
21/10/22
Opyl’s TrialKey achieves major milestone with potential to improve clinical trial success rates
![](https://opyl.ai/wp-content/uploads/2022/10/1-darlinghurst-blog-post-image-20220923134602-392x286.webp)
30/09/22